Evidence map›Paper›PMID 36613675›Full record

ArticleInternational journal of molecular sciences2022

Urine-Derived Epithelial Cells as a New Model to Study Renal Metabolic Phenotypes of Patients with Glycogen Storage Disease 1a.

Livia Lenzini, Elisabetta Iori, Federico Scannapieco, Gianni Carraro, Angelo Avogaro, Nicola Vitturi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. HomozygousRenal failure · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Livia LenziniEmergency Medicine Unit and Specialized Center of Excellence for Hypertension of the European Society of Hypertension, Department of Medicine-DIMED, University Hospital, 35128 Padova, Italy.ORCID 0000-0001-6146-3015
Elisabetta IoriDivision of Metabolic Diseases, Department of Medicine-DIMED, University Hospital, 35128 Padova, Italy.
Federico ScannapiecoDivision of Metabolic Diseases, Department of Medicine-DIMED, University Hospital, 35128 Padova, Italy.
Gianni CarraroNephrology, Dialysis and Transplant Unit, Department of Medicine-DIMED, University Hospital, 35128 Padova, Italy.
Angelo AvogaroDivision of Metabolic Diseases, Department of Medicine-DIMED, University Hospital, 35128 Padova, Italy.
Nicola VitturiDivision of Metabolic Diseases, Department of Medicine-DIMED, University Hospital, 35128 Padova, Italy.ORCID 0000-0002-5147-4367
University of Padua · ITEuropean Society of Hypertension · IT

Funding

University of Padua NA
6 · The paper itself

Abstract

Glycogen storage diseases (GSDs) represent a model of pathological accumulation of glycogen disease in the kidney that, in animal models, results in nephropathy due to abnormal autophagy and mitochondrial function. Patients with Glycogen Storage Disease 1a (GSD1a) accumulate glycogen in the kidneys and suffer a disease resembling diabetic nephropathy that can progress to renal failure. In this study, we addressed whether urine-derived epithelial cells (URECs) from patients with GSD1a maintain their biological features, and whether they can be used as a model to study the renal and metabolic phenotypes of this genetic condition. Studies were performed on cells extracted from urine samples of GSD1a and healthy subjects. URECs were characterized after the fourth passage by transmission electron microscopy and immunofluorescence. Reactive oxygen species (ROS), at different glucose concentrations, were measured by fluorescent staining. We cultured URECs from three patients with GSD1a and three healthy controls. At the fourth passage, URECs from GSD1a patients maintained their massive glycogen content. GSD1a and control cells showed the ciliary structures of renal tubular epithelium and the expression of epithelial (E-cadherin) and renal tubular cells (aquaporin 1 and 2) markers. Moreover, URECs from both groups responded to changes in glucose concentrations by modulating ROS levels. GSD1a cells were featured by a specific response to the low glucose stimulus, which is the condition that more resembles the metabolic derangement of patients with GSD1a. Through this study, we demonstrated that URECs might represent a promising experimental model to study the molecular mechanisms leading to renal damage in GSD1a, due to pathological glycogen storage.

Indexed as

Glycogen Storage DiseaseGlycogen Storage Disease Type IEpithelial CellsGlucoseGlycogenHumansKidneyPhenotypeReactive Oxygen SpeciesGlucoseGlycogenReactive Oxygen Speciesglycogen storage diseasereactive oxygen speciesurine-derived cells

Identifiers

PMID36613675
PMCPMC9820562
OpenAlexW4312117448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.